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S2 
Supplementary Table 1: Descriptive characteristics of the studies included in the systematic review and meta-analysis 
First Author BMI 
(Kg/m2) 
cases 
Criteria or characteristics of patients group Control group criteria or features  NOS 
Georges 
2001 
NA The degree of CAD was assessed by the number of major arteries 
with greater than 50 % stenosis. 
NA 7 
Humphries 
2001 
26.9 NA Free of a history of unstable angina, MI or evidence of 
a silent infarction, coronary surgery, aspirin or antico-
agulant therapy, CVA, malignancy and others. 
7 
Jenny 2002 27 CVD was defined as confirmed angina, MI, stroke, or TIA Composed of randomly selected original cohort mem-
bers who had no prevalent or incident CVD and no 
MRI-detectable infarcts and who did not satisfy the cri-
terion of being free of subclinical CVD. 
7 
Revilla 2002 NA Lacunar stroke was diagnosed if the patient had pure motor hemi-
paresis, sensory-motor syndrome, ataxic hemiparesis, pure sen-
sory syndrome or dysarthria-clumsy hand, respectively, and a brain 
CT scan (100 %) or MRI (90 %) disclosed acute normal findings or 
a deep focal infarction. 
Without history or current symptoms of ischemic or 
hemorrhagic stroke was selected from the same geo-
graphic area random digit dialing. 
7 
Flex 2002  NA Diagnosis of PAOD was performed in accordance with the criteria 
established by the Ad Hoc Committee on Reporting Standards of 
the Society for Vascular Surgery and the International Society for 
Cardiovascular Surgery. 
Exclusion criteria from the study were tumors, chronic 
inflammatory diseases, and autoimmune diseases. 
7 
Nauck 2002 27.52 Inclusion criteria for were German ancestry, clinical stability except 
for acute coronary syndromes, and availability of a CA. Exclusion 
criteria were any acute illness other than acute coronary syn-
dromes, any non-cardiac chronic disease, and a history of malig-
nancy within the past 5 years.  
NA 7 
Basso 2002 26 Individuals who, during 4.8 years of follow-up, experienced a defi-
nite fatal or nonfatal MI or sudden coronary death or who required 
CABG or angioplasty were defined as cases. 
NA 6 
Bennet 2003 26 Subjects that survived 28 days after their first MI, and had no further 
events before blood sampling. 
NA 8 
Greisenegger 
2003 
NA Patients underwent cranial CT or MRI, laboratory investigations for 
vascular risk factors, duplex sonography of the carotid and verte-
bral arteries, and a thorough cardiac investigation.  
Controls were free of clinically manifest vascular dis-
ease and were matched individually to the patients for 
age. 
8 
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S3 
First Author BMI 
(Kg/m2) 
cases 
Criteria or characteristics of patients group Control group criteria or features  NOS 
Stephens 
2004 
29.08 CVD was recorded if a patient had one or more of CHD, PVD or 
CbVD. CHD was recorded if any patient had positive CA or angio-
plasty, coronary artery bypass, a positive cardiac thallium scan or 
exercise tolerance test, documented evidence of myocardial infarc-
tion or symptomatic/treated angina. 
Subjects who were asymptomatic for CHD/ CbVD/PVD 
or had negative investigations were categorized as 
having no CVD.  
7 
Licastro 2004 NA Patients had no history of neoplastic, autoimmune diseases, coag-
ulation disorders or chronic renal failure. 
Free of neoplastic, autoimmune inflammatory diseases 
and in apparent good health. 
8 
Flex 2004 NA The cerebral ischemic event had been documented by CT scan or 
magnetic MRI of the brain. 
Controls had no relationship with cases and no family 
history of stroke. 
6 
Balding 2004 NA Stroke was defined as acute onset of neurological deficit lasting 
more than 24 hours or leading to death with no apparent cause 
other than cerebrovascular disease. 
NA 7 
George 2004 NA NA NA 6 
Lieb 2004 27.8 The diagnosis of MI was established according to the MONICA di-
agnostic criteria. 
NA 8 
Kelberman 
2004 
27.1 MI excluding patients with familial hypercholesterolemia and type 1 
diabetes mellitus. 
NA 8 
Rosner 2005 25.5 MI was confirmed if it met the WHO criteria, which include symp-
toms in the presence of either elevation of cardiac enzymes or di-
agnostic changes on the electrocardiogram. For fatal events, the 
diagnosis of MI was also accepted based on autopsy findings. 
Consisted of those who provided a blood sample at 
baseline and remained free of CVD at the time the in-
dex event occurred in the case subject. 
7 
Karahan 
2005 
NA Stroke was made clinically and the infarction was verified by MRI 
of the brain. 
Unrelated adults living in the same geographic areas 
in Turkey without a personal or family history of stroke. 
8 
Chiapelli 
2005 
5.5 Patients had no history of neoplastic, autoimmune diseases, coag-
ulation disorders or chronic renal failure 
Free of neoplastic, autoimmune and inflammatory dis-
eases and in apparent good health. 
8 
Danielsson 
2005 
NA Recruitment was from patients referred to the Department of Vas-
cular Diseases because of vascular symptoms. 
Healthy blood donors. 7 
Weger 2005 NA Exclusion criteria for patients with RAO comprised giant cell arteri-
tis and other types of vasculitis. 
Subjects with any ophthalmological evidence or history 
of retinal vascular occlusion, anterior ischemic optic 
neuropathy, or vasculitis were not eligible as controls. 
7 
Densem 
2005 
NA CVD was defined as a stenosis of greater than 50 % in one or more 
major epicardial coronary arteries. Two angiographers, blinded to 
clinical and genetic information, independently reviewed all studies. 
NA 6 
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S4 
First Author BMI 
(Kg/m2) 
cases 
Criteria or characteristics of patients group Control group criteria or features  NOS 
Chamorro 
2005 
NA Patients had a brain CT scan or a brain MRI to differentiate be-
tween ischemic and hemorrhagic stroke. Patients also had the nec-
essary diagnostic workup aimed at establishing the stroke subtype, 
including extracranial and transcranial Doppler sonography, ECG, 
MRI, examination of prothrombotic disorders and cerebral angi-
ography. 
Subjects without a history of cerebrovascular symp-
toms were selected by random-digit dialing of the same 
geographic area of residence. 
6 
Sie 2006 26 CHD was defined as the occurrence of an MI, revascularization 
procedure (percutaneous transluminal coronary angioplasty or cor-
onary artery bypass graft), IHD, sudden cardiac death, ventricular 
fibrillation or tachycardia, congestive heart failure, or sudden death 
undefined during follow-up. 
NA 7 
Mysliwska 
2006 
28 Qualification for surgery required that at least one of the major cor-
onary vessels was characterized with ≥ 75 % stenosis. The follow-
ing coronary arteries were affected: LAD or/and RCA or/and CX.  
Never presented clinical symptoms of CHD and had a 
normal resting and exercise-related electrocardiogram. 
They did not have any history of arterial hypertension 
or diabetes mellitus. 
7 
Lalouschek 
2006 
NA The diagnosis was established clinically and all patients underwent 
CT or MRI. 
All were free of clinically manifest arterial vascular dis-
ease and reported no vascular diseases in first-degree 
relatives. Medical history, including a history of febrile 
conditions within the last 4 weeks, vascular risk factors 
and results of laboratory investigation. 
8 
Tütün 2006 -- Patients below 35 years of age who underwent CABG between 
September 2002 and September 2004 constituted the study group. 
Age and sex-matched healthy controls. 6 
Sekuri 2007 26.5 Stenosis of at least 50 % in a major coronary artery, or one of their 
branches, as determined by CA. The extension of disease was de-
fined as the number of arteries with stenosis at least 50 % as single 
or multiple vessels. The CA was performed by Judkin’s method at 
the catheterization laboratories. 
NA 9 
Potacsek 
2007 
-- -- -- 8 
Flex 2007 NA Presence of PAOD at Fontaine’s stage II, III, or IV. Diagnosis of 
PAOD was performed in accordance with the criteria established 
by the Ad Hoc Committee on Reporting Standards of the Society 
for Vascular Surgery and the International Society for Cardiovas-
cular Surgery. 
Subjects presented an ankle/arm pressure index ‡1 
and normal findings at bilateral high-resolution B-mode 
ultrasonography evaluation. Exclusion criteria from the 
study were cancer, chronic inflammatory and infectious 
diseases, and autoimmune diseases. 
7 
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S5 
First Author BMI 
(Kg/m2) 
cases 
Criteria or characteristics of patients group Control group criteria or features  NOS 
Tretjakovs 
2007 
32.9 Coronary artery stenosis >50 %. Healthy subjects 6 
Humphries 
2007 
NA CHD endpoints were acute CHD events, sudden coronary death, 
fatal acute myocardial infarction and non-fatal acute myocardial in-
farction. 
Exclude any CVD. 7 
Smallwood 
2008 
27.2 Men with small AAAs (aortic diameter 30-50 mm) were invited to 
attend a follow-up study (1997-2004) involving repeat ultrasound 
scans at intervals of 6-12 months. At the first follow-up visit, a sam-
ple of venous blood was obtained from all consenting men. Men 
without AAAs were also reviewed as part of a separate study in 
2001-4 which also included venous blood sampling. 
Consisted of randomly selected men with aortic diam-
eters in a previously defined reference range of 19-22 
mm. 
7 
Banerjee 
2008 
NA Subjects were diagnosed at the onset using either CT or MRI. Subjects had vascular risk factors such as hyperten-
sion, diabetes mellitus, smoking habit, and hypercho-
lesterolemia but without any history or occurrence of 
cerebrovascular or CVD. 
7 
Maitra 2008 25.76 The families were recruited through the probands who had a history 
of premature CAD, which included stable and unstable angina and 
MI diagnosed by ECG and treated based on the catheter lab avail-
ability with standard medication or CA followed by PTCA or CABG. 
Individuals who did not have any personal or family his-
tory of CAD, diabetes mellitus or hypertension. 
8 
Smith 2008 28.2 NA NA 7 
Sarecka 
2008 
26.9 CAD with more than 50 % diameter stenosis of at least one of the 
major coronary vessels. 
The exclusion criterion was CAD or stroke revealed in 
the course of family history. CAD in this case was de-
fined by its occurrence in at least one of the parents. 
8 
Silander 
2008 
29* Baseline information on all randomly sampled individuals includes 
anthropometric measurements, serum lipids, blood pressure and 
questionnaire data on CVD risk factors. 
Sub-cohort was sex- and geographic-region stratified 
random sample, drawn from each of the original co-
horts with unequal sampling probabilities so that the 
age distribution was similar to the cases. The selection 
procedure for the cases and the sub-cohort, and the 
exact diagnostic criteria used for CHD and ischemic 
stroke have been described in detail previously. 
7 
Banerjee 
2009 
NA CA showing 50 % stenosis of at least one segment of a major cor-
onary artery was defined as CAD. 
Subjects had vascular risk factors such as hyperten-
sion, diabetes mellitus, and smoking habit but had no 
history of cardiac diseases, no symptoms of other ath-
erosclerotic vascular diseases and had normal ECG. 
8 
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S6 
First Author BMI 
(Kg/m2) 
cases 
Criteria or characteristics of patients group Control group criteria or features  NOS 
Panoulas 
2009 
27 CVD was defined as the presence of cardiovascular death, CHD, 
CVA or PVD. CHD was defined as having any of the following: MI, 
angioplasty, CABG or angina diagnosed by a physician or elicited 
by the use of the Rose questionnaire. 
NA 7 
Berg 2009 NA Significant (>50 %) coronary artery stenosis in at least one main 
coronary artery branch. 
The group had no significant coronary artery stenosis. 7 
Ghazouani 
2010 
27 All patients included had evidence of CAD documented by prior 
cardiac bypass surgery, or documented ACS. CAD was defined as 
50 % stenosis in the left main coronary artery, or multiple significant 
(≥70 % stenosis) in more than one coronary artery. 
They were undergoing a routine check-up as part of 
pre-employment requirements, which included an 
ECG, chest X-ray, and serum analysis. They were 
classified as healthy as their physical examination was 
unremarkable, coupled with the absence of personal or 
family history and reasons to suspect CAD. 
8 
Tong 2010 NA IS was established using the WHO, International Classification and 
stroke subtypes were defined using the Oxford shire classification. 
Subjects with a history of stroke, Alzheimer’s disease, 
brain aneurysm, dementia, dystonia, Parkinson’s dis-
ease or inflammatory disorders were excluded.  
8 
Rios 2010 NA These individuals were classified as CAD if they presented at least 
one obstructive lesion P50 %. 
They were used as controls if they did not show any 
obstructive lesion in the angiography. Moreover, none 
presented MI, cerebral vascular infarction or TIA.  
7 
Fan 2011 NA CHD patients had a medical examination. In general, patients were 
required to have coronary catheterization demonstrating significant 
CHD (at least a 50 % stenosis in one major epicardial coronary 
vessel). 
Subjects without CHD and CP were recruited from a 
community health checkup to match the age and gen-
der distribution of CHD and CP patients as much as 
possible. 
8 
Ghazouani 
2011 
27 Diagnosis of CAD was based on CA (obstructive coronary lesions 
with >50 % narrowing of any subepicardial coronary artery). Deter-
mination of CAD severity was based on the number of major epi-
cardial coronary arteries affected.  
They were required to have a normal physical exami-
nation, a normal resting ECG and no personal or family 
history of CAD. All participants were asked to fill a 
standard questionnaire detailing demographic details, 
together with data on traditional CAD risk factors. 
8 
Coker 2011 28.4 MI was defined using the standard Cardiovascular Health Study 
criteria: history of chest pain, cardiac enzyme levels and character-
istic changes on serial electrocardiograms. 
Patients who came to the hospital due to the chest pain 
and general health ensure checkup. The exclusion cri-
teria were pregnancy, vascular heart disease, atrial fi-
bration, acute or chronic infectious, immunological 
conditions, history of malignancies, neoplastic, coagu-
lation disorders or chronic renal failure. 
9 
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S7 
First Author BMI 
(Kg/m2) 
cases 
Criteria or characteristics of patients group Control group criteria or features  NOS 
Bennermo 
2011 
26.8 They were found to have their first MI were enrolled in a clinical 
research program targeting mechanisms underlying premature 
CHD. 
NA 8 
Vakili 2011 NA MI was established by WHO criteria and was confirmed by CA and 
left ventriculography. However, previous MI was verified by an ep-
isode of persistent ST elevation or depression in ECG and raised 
serum cardiac markers. 
Without evidence of MI, hypertension, diabetes, or car-
diovascular diseases. 
8 
Tuttolomondo 
2012 
NA Stroke was defined by focal neurological signs or symptoms 
thought to be of vascular origin that persisted for >24 h, confirmed 
by brain CT and/or MRI in baseline conditions and brain CT with 
contrast medium after 48–72 h. 
Patients admitted for any cause other than acute car-
diovascular and CVA and for routine checkup exami-
nations. 
7 
Tong 2013 23.2 CA evidence of 70 % stenosis of one major coronary artery, or 50 
% stenosis of the left main coronary artery. Exclusion criteria were: 
current heparin treatment; autoimmune disease; congenital heart 
disease; severe kidney or liver disease; malignancy.  
Subjects with known CAD or any other heart disease 
were excluded from the stud. 
8 
Chakraborty 
2013 
NA Patients with a history of TIA, fever, rheumatologic disease, auto-
immune disease, any acute or chronic infection, CT or MRI proved 
hemorrhagic stroke, and a history of regular immunosuppressive or 
analgesic therapies were excluded. 
Routine laboratory investigations were normal and no 
controls had a history of stroke. The control group was 
expected, a history of hypertension, diabetes and 
dyslipidemia. 
8 
Satti 2013 25.9 CAD in at least two successive generations. The patients were con-
firmed on the basis of CA criteria established by Francois and elec-
trocardiographic features.  
Healthy controls representing the same geographical 
location were included on the basis of normal ECG, 
normal CA, and no history and symptoms of CVD. 
7 
Mishra 2013 24.39 CA identified stenosis >70 % in the major coronary vessels at the 
time of the study were used to classify patients as having single-
vessel, double-vessel, or triple-vessel disease. CAD patients hav-
ing any other cardiac disorder were excluded from the study. 
No clinical evidence of CAD or LV dysfunction and also 
without a positive family history of CAD or MI. 
8 
Bhanushali 
2013 
NA CAD confirmed by CA: >50 % stenosis in one or more arteries and 
stable or unstable angina. 
Examined clinically and investigated by electrocardiog-
raphy to exclude CAD. 
8 
Phulukdaree 
2013 
NA CAD patients were Indian ancestry and unrelated, adults below the 
age of 45 years, and stable CAD confirmed at CA. 
Exclusion criteria for controls were an ACS/revascular-
ization procedure in the preceding 3 months, chronic 
renal or liver disease, malignancy, and known active 
inflammatory or infectious disease. 
7 
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S8 
First Author BMI 
(Kg/m2) 
cases 
Criteria or characteristics of patients group Control group criteria or features  NOS 
Liaquat 2014 22.7 IDC diagnosed on echocardiographic evidence of LV enlargement, 
LV systolic dysfunction (ejection fraction ≤ 40 %), and end-diastolic 
diameter > 34 mm/m2. 
Normal electrocardiograms and ECG with no symp-
toms of any concomitant disease, and had no personal 
or familial history of cardiomyopathy or other heart-re-
lated diseases. 
8 
Galimudi 
2014 
NA Excluding any known cause of myocardial disease. No known history of any disease. 7 
Sun 2014 NA Angiographically documented CAD. CAD or any other heart disease were excluded from 
participation. 
8 
Elsaid 2014 no 
available 
NA e 
CA evidence of ≥ 70 % stenosis of one major coronary artery or 
≥ 50 % stenosis of the left main coronary artery. Exclusion criteria 
included current heparin treatment, autoimmune disease, congen-
ital heart disease, severe kidney or liver disease, or malignancy. 
Subjects had any signs or symptoms suggesting CAD. 7 
Li 2015 NA Obese, subjects having virus C or B were excluded.  Subjects who had a history of CAD or cardiovascular 
disease, autoimmune disease, congenital heart dis-
ease, severe kidney or liver disease, or tumors were 
excluded from the study.  
8 
Spoto 2015 28.2 Using the results of electrocardiography, those who had obstructive 
lesions of more than 50 % in one or more coronary arteries were 
considered to have CAD. 
NA 7 
Yang 2015 NA CKD and history of CVD. MI documented by electrocardiography 
and biomarkers of myocardial injury; heart failure, defined as dysp-
nea in addition to two of the following conditions: raised jugular 
pressure, bibasilar crackles, pulmonary venous hypertension, or in-
terstitial edema on chest radiography requiring hospitalization; 
electrocardiography-documented arrhythmia; stroke; PVD; and 
major arterial or venous thrombotic episodes. 
The control subjects were diagnosed as having no his-
tory of atherosclerotic lesions or CAD. 
8 
Wang 2015 22.8 CAD was diagnosed by CA, and CAD was defined as the presence 
of at least one significant coronary artery stenosis of ≥ 50 % luminal 
diameter, as identified by CA. The patient exclusion criteria were 
myocardial spasms or a myocardial bridge, congenital heart dis-
ease, childhood hypertension, severe kidney or liver disease, or 
malignant tumors. 
Collected from subjects who had taken a health exam-
ination as part of our study. Control subjects who suf-
fered from CAD or any other heart disease were ex-
cluded from the study. 
8 
Salama 2015 NA Diagnosed by CA evidence of ≥ 70 % stenosis of one major coro-
nary artery, or ≥ 50 % stenosis of the left main coronary artery. 
Third control group includes 34 volunteers with no pre-
vious history of TIA.  
7 
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S9 
First Author BMI 
(Kg/m2) 
cases 
Criteria or characteristics of patients group Control group criteria or features  NOS 
Patients who had an autoimmune disease, congenital heart dis-
ease, severe kidney or liver disease, or malignancy were excluded 
from our study. 
Buraczynska 
2016 
28.1 Multiple TIAs history with at least one recent attack (high-risk TIA) 
and with one TIA over the last year (low-risk TIA). 
Without a history of diabetes or cardiovascular events 
and no signs of dysfunction of the cardiovascular sys-
tem upon examination. 
8 
Hongmei 
2016 
26.41 T2DM with CVD. CVD was defined as congestive heart failure, is-
chemic cerebral stroke, or peripheral arteriopathy. 
Confirmed to be free of coronary artery diseases and 
other CVD, end-stage renal and liver disease, serious 
infections, malignant tumor, thyroid disease and im-
mune system diseases. 
9 
Mao 2016 24.61 CAD was defined as follows: luminal stenosis above 50 % in one 
of the main coronary arteries or their branch retinal arteries, and 
exhibiting stable angina, unstable angina pectoris and MI. 
Subjects were randomly selected from the physical ex-
amination center or the outpatient clinics at the Henan 
Provincial People’s Hospital. These subjects were con-
firmed to have no history of arteriosclerotic lesions or 
CVD. 
8 
Kou 2017 25.8 CAD was defined as a diameter stenosis of above 70 % in any main 
coronary arteries. Patients who had malignancies, myocardial 
spasms, myocardial bridges, as well as those suffering from auto-
immune diseases, congenital heart diseases, or end-stage kidney 
or liver diseases were excluded from the study. 
Diabetes, hypertension, hyperlipidemia, and missing 
data and those with BMI < 18.5 kg/m2. 
8 
Jun 2017  24.7 ITC (cardiac catheterization, percutaneous coronary intervention, 
or coronary artery bypass grafting), stable angina pectoris, unsta-
ble angina pectoris, the first occurrence of acute MI, congestive 
heart failure caused by myocardial ischemia after baseline investi-
gation, ischemic stroke, hemorrhagic stroke, and peripheral vascu-
lar disease, or cardiovascular death. 
The controls were randomly selected from those, who 
received a physical examination in our hospital and 1:1 
matched to cases on the basis of age and sex, all se-
lected controls received electrocardiographic testing 
and CA, and those with abnormal electrocardiographic 
and CA profile were excluded. 
8 
Mitrokhin 
2017 
30.71 CHD patients were diagnosed by at least two experienced cardiol-
ogists and were confirmed by CA (> 50 % diameter stenosis in at 
least one of the major coronary arteries) according to the WHO cri-
teria for the CHD confirmation. 
The control subjects were confirmed to be free of CAD 
and other CVD, end-stage renal and liver diseases, 
thyroid disease, malignant tumor, immune system dis-
eases, and serious infections.  
8 
Mastana 
2017 
NA The basic criteria for inclusion in the group with CAD was ≥ 50 % 
stenosis in at least one coronary artery (left main coronary steno-
sis, right coronary artery, anterior descending branch, and CX) and 
exhibiting stable or unstable angina pectoris. 
Controls had no known history of IHD, hypertension, 
diabetes, endocrine or metabolic disorders and were 
selected after administration of a treadmill exercise test 
9 
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S10 
First Author BMI 
(Kg/m2) 
cases 
Criteria or characteristics of patients group Control group criteria or features  NOS 
to exclude the possibility of the patients having an un-
derlying CAD. 
Jabir 2017 28.69 Patients were classified on the basis of at least 50 % or more ste-
nosis in one or more coronary arteries verified through CA. 
Healthy subject 7 
Akinyemi 
2017 
NA CAD was diagnosed by CA and other routinely used biological pa-
rameters.  
NA 7 
Peripheral vascular disease (PVD); cerebrovascular disease (CbVD); magnetic resonance imaging (MRI); left anterior descending (LAD); right coronary artery 
(RCA), circumflex artery (CX); computed tomography (CT); coronary angiography (CA); echocardiogram (ECG); transluminal coronary angioplasty (PTCA); 
coronary artery bypass graft (CABG); cerebrovascular accident (CVA), peripheral vascular disease (PVD); acute coronary syndrome (ACS); idiopathic dilated 
cardiomyopathy (IDCM); left ventricular (LV); interventional therapy of coronary (ITC); ischemic heart disease (IHD); transient ischemic attack (TIA); Abdominal 
aortic aneurysm (AAA);  not available (NA). 
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S11 
Supplementary Table 2: Meta-analysis of the association between rs1800795 polymorphism and cardiovascular disease risk in accordance with the geograph-
ical location in which the studies were performed.  
Study 
groups  Allele  Homozygote 
 Heterozygote 
  OR (95% CI) P  I2  Q Egger  OR (95% CI) P  I2  Q  Egger  OR (95% CI) P  I2  Q  Egger 
Overall 74 1.43(1.06-1.22) <0.001 82.32 <0.00 0.398 70 1.24(1.08-1.42) 0.002 75.40 <0.00 0.360 71 1.14(1.04-1.24) 0.003 72.20 <0.00 0.399 
 52 1.06(1.02-1.10) 0.001 15.56 0.172 0.943 49 1.11(1.03-1.19) 0.006 11.11 0.256 0.184 62 1.08(1.03-1.12) <0.00 0.000 0.608 0.675 
China 11 1.36(1.26-1.48) <0.001 5.466 0.391 0.663 8 1.91(1.61-2.27) <0.001 0.000 0.734 0.184 11 1.21(1.09-1.34) <0.00 0.000 0.843 0.179 
United 
Kingdom 9 1.19(0.95-1.49) 0.111 88.28 <0.00 0.128 9 1.26(0.84-1.89) 0.261 84.65 <0.00 0.442 9 1.16(0.96-1.39) 0.114 52.95 0.030 0.292 
 7 0.99(0.92-1.08) 0.987 0.000 0.815 0.591 7 0.94(0.79-1.11) 0.488 0.000 0.862 0.469 8 1.16(1.02-1.31) 0.018 10.38 0.350 0.358 
Turkey 4 1.07(0.75-1.53) 0.676 52.02 0.100 0.226 4 1.02(0.43-2.41) 0.957 44.43 0.145 0.157 4 1.00(0.75-1.34) 0.967 0.000 0.929 0.499 
 3 0.94(0.74-1.19) 0.621 0.000 0.908 0.408 3 0.81(0.44-1.48) 0.495 0.000 0.877 0.117       
India 8 0.93(0.73-1.17) 0.550 58.26 0.019 0.737 8 0.89(0.47-1.67) 0.730 37.42 0.131 0.993 8 0.91(0.67-1.24) 0.584 62.78 0.009 0.640 
 7 1.05(0.89-1.24) 0.536 0.000 0.626 0.106 7 1.26(0.71-2.23) 0.415 0.000 0.464 0.200 7 1.05(0.86-1.28) 0.610 0.000 0.563 0.968 
Europeans 37 1.10(0.99-1.21) 0.059 86.63 <0.00 0.581 36 1.08(0.91-1.28) 0.349 79.72 <0.00 0.911 35 1.18(1.02-1.36) 0.022 83.47 <0.00 0.536 
 27 1.03(0.99-1.07) 0.130 12.04 0.286 0.900 27 1.04(0.96-1.13) 0.305 4.894 0.392 0.084 26 1.05(0.98-1.12) 0.123 11.36 0.298 0.174 
Africans 3 0.91(0.64-1.30) 0.637 59.15 0.086 0.296 3 0.94(0.28-2.86) 0.864 47.92 0.142 0.296 3 1.03(0.77-1.38) 0.801 0.000 0.553 0.877 
   
Study 
groups Dominant Recessive 
  OR (95% CI) P  I2  Q Egger  OR (95% CI) P  I2  Q  Egger 
Overall 74 1.16(1.06-1.27) 0.001 76.18 <0.00 0.404 71 1.18(1.04-1.34) 0.008 77.66 <0.00 0.450 
 60 1.12(1.07-1.18) <0.001 13.26 0.197 0.504 53 1.05(0.98-1.12) 0.124 10.41 0.262 0.634 
China 10 1.16(1.05-1.27) 0.002 0.000 0.998 0.596 8 1.78(1.51-2.10) <0.001 0.000 0.717 0.720 
United 
Kingdom 9 1.15(1.00-1.31) 0.039 29.28 0.185 0.166 9 1.25(0.73-2.13) 0.399 92.70 <0.00 0.387 
 8 1.10(0.98-1.23) 0.095 6.137 0.383 0.350 7 0.86(0.74-1.00) 0.055 0.000 0.921 0.235 
Turkey 4 1.01(0.77-1.34) 0.911 0.000 0.519 0.243 4 1.01(0.43-2.35) 0.971 44.01 0.147 0.170 
       3 0.81(0.45-1.47) 0.496 0.000 0.843 0.108 
India 8 0.91(0.67-1.22) 0.540 64.32 0.006 0.811 8 0.97(0.59-1.58) 0.912 12.77 0.330 0.675 
 7 1.05(0.87-1.27) 0.564 0.000 0.660 0.458       
Europeans 37 1.17(1.02-1.35) 0.018 83.97 <0.00 0.337 37 1.02(0.87-1.20) 0.764 82.57 <0.00 0.689 
 29 1.07(1.00-1.14) 0.026 19.70 0.174 0.191 28 1.01(0.95-1.09) 0.592 0.000 0.515 0.599 
Africans 3 0.94(0.57-1.54) 0.814 31.68 0.231 0.758 3 0.93(0.49-1.79) 0.843 37.73 0.201 0.654 
EXCLI Journal 2019;18:331-355 – ISSN 1611-2156 
Received: March 06, 2019, accepted: April 09, 2019, published: June 07, 2019 
 
 
S12 
Supplementary Table 3: Meta-analysis of the association between rs1800795 polymorphism and clinical diagnosis 
Pathologies  Allele  Homozygote 
  OR (95% CI) P  I2  Q  Egger  OR (95% CI) P  I2  Q  Egger  
CAD 27 1.16(1.03-1.30) 0.011 73.17 <0.00 0.386 26 1.39(1.11-1.74) 0.004 0.58 <0.00 0.514 
 19 1.14(1.04-1.23) 0.002 21.14 0.197 0.692 18 1.50(1.28-1.76) <0.001 0.000 0.522 0.148 
PAOD 4 0.72(0.46-1.11) 0.142 79.38 0.002 0.618 4 0.52(0.24-1.11) 0.094 73.21 0.011 0.588 
MI 13 1.08(0.99-1.18) 0.083 69.06 <0.00 0.115 13 1.16(0.96-1.40) 0.112 68.21 <0.00 0.093 
 10 1.00(0.92-1.05) 0.832 0.000 0.561 0.887 12 1.03(0.93-1.15) 0.498 12.02 0.327 0.164 
IS 10 0.92(0.73-1.16) 0.498 76.21 <0.00 0.991 9 0.86(0.47-1.59) 0.649 78.37 <0.00 0.645 
 9 1.02(0.91-1.14) 0.671 0.000 0.497 0.392 6 1.07(0.73-1.58) 0.703 3.559 0.394 0.531 
HC 53 1.23(1.12-1.34) <0.001 81.19 <0.00 0.450 50 1.42(1.20-1.67) <0.001 69.96 <0.00 0.300 
 33 1.12(1.07-1.18) <0.001 0.000 0.642 0.100 35 1.23(1.11-1.37) <0.001 5.150 0.382 0.879 
 Dominant Recessive 
  OR (95% CI) P  I2  Q Egger  OR (95% CI) P  I2  Q  Egger  
CAD 27 1.15(1.02-1.30) 0.019 56.72 <0.00 0.646 26 1.32(1.08-1.61) 0.005 57.39 <0.00 0.912 
 25 1.23(1.11-1.35) <0.001 20.82 0.175 0.836 18 1.31(1.10-1.56) 0.002 15.54 0.268 0.232 
PAOD 4 0.80(0.42-1.50) 0.487 78.20 0.003 0.347 4 0.52(0.31-0.86) 0.012 52.95 0.095 0.894 
       3 0.39(0.26-0.59) <0.001 0.000 0.543 0.305 
MI 13 1.11(0.97-1.27) 0.099 69.58 <0.00 0.084 13 1.09(0.95-1.25) 0.202 54.87 0.009 0.184 
 9 0.96(0.89-1.04) 0.394 0.000 0.960 0.742 12 1.02(0.94-1.11) 0.594 0.000 0.944 0.476 
IS 10 0.93(0.70-1.23) 0.614 60.31 0.007 0.765 9 0.84(0.54-1.30) 0.442 76.71 <0.00 0.930 
 9 1.07(0.89-1.29) 0.427 0.856 0.427 0.180 8 0.99(0.79-1.25) 0.977 18.68 0.282 0.641 
HC 53 1.28(1.14-1.44) <0.001 77.17 <0.00 0.451 50 1.31(1.11-1.54) <0.001 76.56 <0.00 0.309 
 43 1.24(1.16-1.31) <0.001 4.082 0.392 0.216 37 1.02(0.95-1.10) 0.519 0.000 0.544 0.671 
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Supplementary Table 3 (cont.): Meta-analysis of the association between rs1800795 polymorphism and clinical diagnosis 
Pathologies Heterozygote 
  OR (95% CI) P  I2  Q Egger 
CAD 26 1.07(0.97-1.19) 0.152 30.93 0.069 0.759 
 25 1.10(1.02-1.19) 0.013 0.000 0.804 0.439 
PAOD 4 0.97(0.52-1.79) 0.928 72.94 0.011 0.362 
MI 13 1.09(0.96-1.24) 0.155 63.45 <0.00 0.086 
 10 0.98(0.91-1.06) 0.741 0.000 0.595 0.868 
IS 10 0.98(0.79-1.23) 0.918 33.57 0.139 0.431 
 9 1.07(0.88-1.32) 0.469 10.01 0.352 0.164 
HC 52 1.23(1.09-1.40) <0.001 76.61 <0.00 0.754 
 42 1.17(1.10-1.24) <0.001 0.000 0.901 0.366 
 
 
 
 
Supplementary Table 4: Meta-analysis of the association between rs1800795 polymorphism and smoking habits 
Study groups Smokers vs non-smokers 
 (n)   OR (95% CI) P  I2  Q  Egger  
Allelic 6 1.13(0.97-1.31) 0.116 62.54 0.020 0.707 
 3 1.34(0.94-1.92) 0.103 29.03 0.244 0.296 
Homozygous 6 1.10(0.83-1.46) 0.499 55.23 0.048 0.132 
 5 1.01(0.88-1.16) 0.853 10.80 0.344 0.807 
Heterozygous 6 1.18(0.54-2.54) 0.672 97.17 0.000 0.170 
 3 1.08(0.70-1.67) 0.724 0.000 0.824 0.624 
Dominant 6 1.18(0.74-1.87) 0.472 92.72 0.000 0.169 
 3 1.28(0.85-1.91) 0.226 0.000 0.534 0.632 
Recessive 6 1.11(0.67-1.83) 0.685 89.64 0.000 0.130 
 3 1.18(0.73-1.91) 0.480 0.000 0.420 0.792 
(n)= studies included  
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Supplementary Figures 
 
 
 
 
 
Funnel plot of the allelic model in the CAD population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the allelic model in the China population group in absence of heterogeneity 
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Funnel plot of the allelic model in the European population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the allelic model in the European population group in absence of heterogeneity 
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Funnel plot of the allelic model in the Indian population group in absence of heterogeneity 
 
 
 
 
Funnel plot of the allelic model in the IS population group in absence of heterogeneity 
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Funnel plot of the allelic model in the MI population group in absence of heterogeneity 
 
 
 
 
Funnel plot of the allelic model in the Overall population group in absence of heterogeneity 
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Funnel plot of the allelic model in the Turkish population group in absence of heterogeneity 
 
 
 
 
Funnel plot of the allelic model in the UK population group in absence of heterogeneity 
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Funnel plot of the allelic model in the African population group with moderate heterogeneity 
 
 
 
 
Funnel plot of the allelic model in the PAOD population group with high heterogeneity 
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Funnel plot of the allelic model in the European population with CAD in absence of heterogeneity 
 
 
 
 
Funnel plot of the allelic model in the European population with IS in absence of heterogeneity 
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Funnel plot of the allelic model in the European population with MI in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the allelic model in the Indian population with CAD in absence of heterogeneity 
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Funnel plot of the dominant model in the CAD population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the dominant model in the Chinese population group in absence of heterogeneity 
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Funnel plot of the dominant model in the European population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the dominant model with healthy subjects as control group in absence of heterogeneity 
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Funnel plot of the dominant model in the Indian population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the dominant model in the IS population group in absence of heterogeneity 
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Funnel plot of the dominant model in the MI population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the dominant model in the Overall population group 
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Funnel plot of the dominant model in the Turkish population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the dominant model in the UK population group in absence of heterogeneity 
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Funnel plot of the dominant model in the African population group with low heterogeneity 
 
 
 
 
 
Funnel plot of the dominant model in the PAOD population group with high heterogeneity 
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Funnel plot of the dominant model in the European population with CAD in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the dominant model in the European population with IS in absence of heterogeneity 
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Funnel plot of the dominant model in the European population with MI in absence of heterogeneity 
 
 
 
 
 
 
Funnel plot of the dominant model in the Indian population with CAD in absence of heterogeneity 
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Funnel plot of the heterozygous model in the CAD population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the heterozygous model in the Chinese population group in absence of heterogeneity 
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Funnel plot of the heterozygous model in the European population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the heterozygous model with healthy subjects as control group in absence of heteroge-
neity 
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Funnel plot of the heterozygous model in the Indian population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the heterozygous model in the IS population group in absence of heterogeneity 
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Funnel plot of the heterozygous model in the MI population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the heterozygous model in the Overall population group in absence of heterogeneity 
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S34 
Funnel plot of the heterozygous model in the Turkish population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the heterozygous model in the UK population group in absence of heterogeneity 
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Funnel plot of the heterozygous model in the African population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the heterozygous model in the PAOD population group with high heterogeneity 
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Funnel plot of the heterozygous model in the European population with CAD in absence of heteroge-
neity 
 
 
 
 
 
Funnel plot of the heterozygous model in the European population with IS in absence of heterogeneity 
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Funnel plot of the heterozygous model in the European population with MI in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the heterozygous model in the Indian population with CAD in absence of heterogeneity 
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Funnel plot of the homozygous model in the CAD population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the homozygous model in the Chinese population group in absence of heterogeneity 
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Funnel plot of the homozygous model in the European population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the homozygous model with healthy subjects as control group in absence of heteroge-
neity 
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Funnel plot of the homozygous model in the Indian population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the homozygous model in the IS population group in absence of heterogeneity 
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Funnel plot of the homozygous model in the MI population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the homozygous model in the Overall population group in absence of heterogeneity 
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Funnel plot of the homozygous model in the Turkish population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the homozygous model in the UK population group in absence of heterogeneity 
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Funnel plot of the homozygous model in the African population group with low heterogeneity 
 
 
 
 
 
Funnel plot of the homozygous model in the PAOD population group with high heterogeneity 
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Funnel plot of the homozygous model in the European population with CAD in absence of heterogene-
ity 
 
 
 
 
 
Funnel plot of the homozygous model in the European population with IS in absence of heterogeneity 
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Funnel plot of the homozygous model in the European population with MI in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the homozygous model in the Indian population with CAD in absence of heterogeneity 
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Funnel plot of the recessive model in the CAD population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the recessive model in the Chinese population group in absence of heterogeneity 
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Funnel plot of the recessive model in the European population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the recessive model with healthy subjects as control group in absence of heterogeneity 
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Funnel plot of the recessive model in the Indian population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the recessive model in the IS population group in absence of heterogeneity 
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Funnel plot of the recessive model in the MI population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the recessive model in the Overall population group in absence of heterogeneity 
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Funnel plot of the recessive model in the Turkish population group in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the recessive model in the UK population group in absence of heterogeneity 
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Funnel plot of the recessive model in the African population group with low heterogeneity 
 
 
 
 
 
Funnel plot of the recessive model in the PAOD population group in absence of heterogeneity 
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Funnel plot of the recessive model in the European population with CAD in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the recessive model in the European population with IS in absence of heterogeneity 
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Funnel plot of the recessive model in the European population with MI in absence of heterogeneity 
 
 
 
 
 
Funnel plot of the recessive model in the Indian population with CAD in absence of heterogeneity 
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